Pobilukast

N/A

Report date: 2022/05/16 08:59:53
NME

Base Information

Drug NamePobilukast
Drug Alias Name泊比司特SKF-104353SK&F-104353SKF-S-104353SK&F-104353-Q +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonists
TargetsCysteinyl leukotriene receptor 1
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksKEGG